Abstract. We have compared the intracellular transport and subcellular distribution of MHC class IIinvariant chain complexes in a wild-type HLA-DR3 homozygous cell line and a mutant cell line, T2.DR3. The latter has a defect in antigen processing and accumulates HLA-DR3 molecules associated with an invariant chain-derived peptide (CLIP) rather than the normal complement of peptides derived from endocytosed proteins. We find that in the wild-type cells, CLIP is transiently associated with HLA-DR3 molecules, suggesting that the peptide is a normal class H-associated intermediate generated during proteolysis of the invariant chain. In the mutant cell line proteolysis of the invariant chain is less efficient, and HLA-DR3/CLIP complexes are generated much more slowly. Examination of the mutant cell line by immunoelectronmicroscopy shows that class II-invariant chain complexes accumulate intracellularly in large acidic vesicles which contain lysosomal markers, including fl-hexosaminidase, cathepsin D, and the lysosomal membrane protein CD63. The markers in these vesicles are identical to those seen in the class II-containing vesicles (MIICs) seen in the wild-type cells but the morphology is drastically different. The vesicles in the mutant cells are endocytic, as measured by the internalization of BSA-gold conjugates. The implication of these findings for antigen processing in general and the nature of the mutation in particular are discussed.
slowly. Examination of the mutant cell line by immunoelectronmicroscopy shows that class II-invariant chain complexes accumulate intracellularly in large acidic vesicles which contain lysosomal markers, including fl-hexosaminidase, cathepsin D, and the lysosomal membrane protein CD63. The markers in these vesicles are identical to those seen in the class II-containing vesicles (MIICs) seen in the wild-type cells but the morphology is drastically different. The vesicles in the mutant cells are endocytic, as measured by the internalization of BSA-gold conjugates. The implication of these findings for antigen processing in general and the nature of the mutation in particular are discussed.
M
AJOR histocompatibility complex (MHC) ~ molecules present antigenic peptides to T cells during an immune response. Class I molecules present peptides from cytosolic proteins to CD8+ T cells (Townsend and Bodmer, 1989) , while class II molecules predominantly present peptides from exogenous proteins to CD4+ T ceils (Unanue, 1984) . Intracellularly, class 11 molecules associate with a third protein, the invariant (I) chain (Jones et al., 1979; Machamer and Cresswell, 1982) . I chain associates with class II heterodimers in the endoplasmic reticulum (ER) in a nine-chain complex consisting of a core I chain trimer with three associated heterodimers (Marks et al., 1990; . This complex contains no detectable associated antigenic peptides (Roche and Cresswell, 1990; Newcomb and Cresswell, 1993; Roche et al., 1992) . Once assembled, the ot/3I complex traverses the Golgi stacks and is sorted to a compartment that is both acidic and endocytic (Lotteau et al., 1990; Lamb et al., 1991; Bakke and Dobberstein, 1990 ). The key signal for this sorting event resides in the cytoplasmic domain of the I chain (Bakke and Dobberstein, 1990 ). In Epstein Ban" virus (EBV)-transformed human B-cell lines this compartment has been extensively characterized by electron microscopy. It shares features characteristic of lysosomes, and has been designated the MHC-class H-containing compartment (MIIC) (Peters et al., 1991b) . Biosynthetic studies of class II molecules in vivo have shown that I chain is proteolytically degraded, probably in this endocytic compartment Nguyen et al., 1989) , releasing otfl dimers which are competent to bind antigenic peptides Newcomb and Cresswell, 1993) . Thus, the efficient degradation and complete dissociation of I chain is critical for the class II complex to fulfill its function of presenting antigenic peptides to T cells.
Maturation of class II molecules in vivo, dissociation of I chain, and peptide binding correlates with the acquisition of an SDS-stable phenotype for class II ot/~ dimers (Germain and Hendrix, 1991) . HLA-DR3 molecules from cell lines defective in class H-restricted antigen processing, have been shown to be SDS-unstable (Mellins et al., 1990; . Further, the class II molecules purified from two such mutant cell lines expressing HLA-DR3 lack a wild-type repertoire of endogenously bound peptides and are instead primarily associated with high levels of a nested set of invariant chain-derived peptides (class IIassociated invariant chain-derived peptides or CLIP Sette et al., 1992] ). Peptides generated from the same region of I chain have also been isolated from wild-type class II molecules indicating that such peptides are not solely generated in mutant cell lines (Chicz et al., 1992; Rudensky et al., 1991; Hunt et ai., 1992) . Here we show that in wild-type cells HLA-DR3 or/3 dimers are transiently associated with CLIP during intracellular transport. In contrast, the mutant cell line T2.DR3 accumulates ot/3CLIP complexes during biosynthesis and ultimately expresses these complexes at the cell surface. Electron microscopy reveals an accumulation of class II molecules in T2.DR3 cells in large vesicular compartments. These contain many of the markers characteristic of the class H-containing compartment seen in wild-type B-cell lines, but differ drastically in morphology. We propose that the defect in antigen processing in the mutant cells induces the accumulation of class II molecules in this compartment, and that this accumulation induces its distention.
Materials and Methods

Cell Lines
The cell lines T1.DR3, T2.DR3, and Pala have been previously described and were cultured in Iscove's Duibecco's modified medium 0MDM, GIBCO BRL, Galthersburg, MD) with 5 % calf serum (CS, Gibco) at 37°C.
Radiolabeling
Continuous metabolic labels were performed as described (Machamer and Cresswell, 1982) . Cells were preincubated in methionine-free DME, supplemented with L-glutamine, 3% dialyzed FCS, and 0.5% gentamicin (all from Gibco) for 1 h at 37°C. Cells were then resuspended in methioninefree medium described above and labeled at 37°C with [35S]methionine trans-label (ICN, K & K laboratories, Inc., Plainview, NJ). For pulse-chase experiments, cells were preincubated as described above, labeled with [35S]methioulne trans-label (ICN) and chased in IMDM (G-ibco) supplemented with 5% calf serum, 0.5% gentamicin, and a 15-fold excess of cold methionine (Sigma Chem. Co., St. Louis, MO).
Immunoprecipitations
Metabolically labeled cells were extracted in 1% Triton X-100 (TX-100, Sigma Chem. Co.), 0.1 mM tosyllysine chloromethyl ketone (TLCK, Sigma Chemical Co.) and 0.5 mM PMSF (Sigma Chem. Co.) in Tris-saline, pH 7.4 (TS, pH 7.4, 10 mM Tris and 0.15 M NaC1, both from Sigma Chem. Co.). Extraction was performed on ice at 2 x 106 cells per ml for 30 rain with occasional agitation. Nuclei were pelleted at 1,000 g for 10 rain at 4°C. The lysate was clarified by centrifugation for 10 min at 14,000 rpm in a microcentrifuge. Supernatants were precleared with 2/~1 rabbit anti-human immunoglobulin and 30/~1 protein A-Sepharose CL-4B (both from Sigma Chem. Co.) at 4°C for 1 h. Lysates were then incubated with specific antibody for 1 h at 4°C and subsequently incubated for an additional hour with 30 ~tl protein A-Sepharose at 4oc. The beads were then washed four times with 0.05% TX-100 in TS, pH 7.4.
One-Dimensional Gel Analysis
SDS-PAGE was performed as described (Laemmli, 1970) . All gels contained a final concentration of 10.5% acrylamide and were 1.5-ram thick. Gels were fixed in 7.5% acetic acid and 5% MeOH for at least 30 rain, and then immersed for 30 min in 100 ml of Enlightnin$ (Dupont, New England Nuclear, Boston, MA) for fluorography, before drying.
Affinity Purification
Metabolically labeled cells were lysed in 2 % polyoxyethylene 9 lauryl ether (C12 Eg, Sigma Chem. Co.), 03 mM TLCK, 0.5 mM PMSF, 5 mM iodoacetamide, 0.02% NaN3 (all from Sigma Chem. Co.) in TS, pH 7.4 for 45 rain on ice, with occasional agitation. Extraction concentration was 106 cells per mi of lysis buffer. Nuclei were pelleted at 1,000 g, 4°C, and removed. The extract was further clarified by ultracentrifugetion at 100,000 g for 1 h, 4°C. HLA-DR3 molecules were purified by immnnoaflinity chromatography, using a mouse immunoglobulin precoluum connected in series to a L243 (HLA-DR specific mAb) affinity column as previously described ). The specific columns were then washed with 200 ml of 0.5 % deoxycholate (DOC) and 0.02 % NaN3 in TS, pH 8.0, reequilibrated in 1% N-octylglucoside (Boehringer Mannheim, Indianapolis, IN), 0.02% NaN3 in TS, pH 8.0, and purified molecules were eluted with 0.1 M Tris, pH 11.5, 1% N-octyglucoside and 0.02% NAN3. Immediately after elution the fractions were neutralized by addition of 1 M acetic acid (Fischer Co., Pittsburgh, PA) and the peak radioactive fractious were pooled and stored at 4°C until use. For preparations to be analyzed by ~versed-phase HPLC, 0.1% Ct2E9 was used in the reequilibratlon and elution buffers instead of 1% N-octylglucoside.
Separation of Bound Peptides from Purified
Class H Complexes
Class II molecules purified by aifinity chromatography were denatured by addition of acetic acid to a final concentration of 10%. The peptides were immediately separated by centrifugation through a Centricon 10 filtration unit (Amicon, Danvers, MA) at 7,000 rpm for 50 vain at room temperature. The ct-and/~-chains were retained above the filter.
HPLC Analysis of Peptides
Endogenous peptides purified as described above were analyzed by HPLC using a Delta-Pak analytical C18 column (Waters Chromatography Division, Milford, MA). Peptide samples were adjusted to a final concentration of 0.1% hydrochloric acid (Pierce Chem. Co., Rockford, IL)and subjected to chromatography with the following gradient: 0 %-15 % acetonitrile from 0-20 min and 15-45% acetonitrile from 20-120 min at a flow rate of 0.5 ml/min.
Tris-tricine Gel Electrophoresis
Electrophoresis conditions were performed as described by Shagger and von Jagow (1987) . The stock acrylamide solution used in these experiments was designated by Shagger and yon Jagow as 49.5%% 3%C (48% acrylamide, 1.5 % N,N-methylenebisacrylamide, Bio-rad Labs., Hercules, CA). 1.5-cm stacker gel was polymerized on top of 1.5-cm spacer gel and '~6.5-cm separating gel (using the separating gel recipe designated as 16.5 %% 3 %C). Both the spacer and separating gels were copolymerized. Samples were run into the stacker gel at 30 V, and then run to the bottom of the gel at 60 V. Upon completion, gels were immediately placed in 100 nd of 10% MeOH, 10% acetic acid, 5% glycerol and rocked for 30 rain at room temperature. Gels were briefly rinsed with H20 and placed in 100 ml of EnlighUfing with 5 % glycerol added (rocking at room temperature for 30 rain). Gels were dried in two cycles with continuous vacuum as follows: 2.5 h with a slow increase in temperature to 60°C, and then 2 more h with a rapid rise in temperature to 80°C.
Cell Surface Biotinylation
Radiolabeled cells were pulsed and chased as described above. At the end of the chase period, the cells were washed once in PBS and resuspended at 2 x 106 cells per ml in ice cold bicine-saline, pH 7.5 (BS, 130 mM NaC1, 20 mM bicine, Sigma Chem. Co.). Sulfosuocinimidyl-6-(biotinamido) hexanoate (NHS-LC-Biotin, Pierce Chem. Co.) was added to a final concentration of 0.2 mM and the cells incubated for 30 rain on ice. The reaction was stopped by addition of I M glycine (Sigma Chem. Co.) to a final concentration of 10 mM and the cells pelleted by centrifugation, 1,000 rpm, 10 min, 4°C. Pellets were stored at -20°C. Cells were then ex-tracted, precleared, and immunoprecipitated as described above. Pellets were washed four times with TS, pH 7.4, 0.05 % TX-100. Protein was eluted from the beads with 100 #1 of elution buffer, pH 11.5 (described above for affinity purification), for 5 min on ice. Supernatants were removed and neutralized by addition of 7 t~l 1 M acetic acid. 1 ml of 0.1% C12E9 column buffer and BSA to a final concentration of 1% was added to each sample and biotinylated cell surface proteins were specifically precipitated by rocking at 4"C with avidin-agarose beads that had been precoated with FCS to prevent non-specific sticking. Pellets were washed four times with "IS, pH 7.4, 0.05% TX-100, and solubilized in 50 ml of tricine sample buffer, before analysis with Tris-tricine acrylamide gels.
Electron Microscopy
For studying the morphology, T1.DR3, T2, and T2.DR3 cells were fixed in Karnovsky and embedded in Epon. Ultrathin sections were stained in uranyl Mg-acetate and Reynolds lead citrate. For immuno-electron microscopy, TI.DR3, T2, and T2.DR3 cells were fixed in a mixture of 2% paraforrnaldehyde and 0.5 % glutaraldehyde (final concentrations) in 0.1 M sodium phosphate, pH 7.4 for 2 h and shipped in 1% paraformaldehyde in the same buffer for further processing. Cell samples were embedded in 10% gelatin which was solidified on ice. Blocks were immersed in 2.3 M sucrose in phosphate buffer for 2 h at 4"C and ultrathin cryosections were single and double immuno-labeled as described with 10-and 15-nm protein-A conjugated colloidal gold probes. The antibodies used were rabbit antibodies against human cathepsin D (Geuze et al., 1988); human CD63 (Metzelaer et al., 1991) ; human class II (Peters et al., 1991b) , DNP (Dakopetts, Glostrup, Denmark); CI-MPR (Geuze et al., 1988) ; I chain (Marks et al., 1990) , and a mouse monoclonal antibody (PIN.l) against a synthetic peptide corresponding to the cytosolic tail of I chain (Lamb and Cresswell, 1992) .
To study endocytic compartments, T1.DR3 and T2.DR3 were pulse incubated with 5-nm BSA/gold particles (OD, 10) for 10 rnin, and chased for 0, 30, 60, and 120 rain at 370C. Endocytosis was stopped in ice-cold medium and the cells were washed twice in cold medium to remove most of the surface-adhered gold. Cells were then fixed and processed as above. To detect acidic compartments at the EM level, T1.DR3 and T2.DR3 were incubated with 30 #M of the weak base 3-(2,4-dinitroanilino)-3-amino-Nmethyldipropylamine, DAMP (Anderson et al., 1984) at 37"C for 30 rain and washed with ice-cold serum-free medium at 0*C for 4 min to remove cytoplasmic DAMP. The DAMP-treated cells were fixed and processed for immunogold labeling as above.
Results
Kinetics of Transport and Processing of HLA-DR3 Molecules
Class II molecules are posttranslationally modified by the addition of N-linked glycans in the ER. As the molecules traverse the Golgi, the oligosaccharides are trimmed and modified (Machamer and Cresswell, 1982) . Sialic acid is added in the trans-Golgi and serves as a convenient marker for transport to the compartment. Previous studies of the biosynthesis of murine I-A k molecules in T1 and T2 showed that sialylated class II-invariant chain complexes were generated with similar kinetics in both parent and mutant cell lines . Similar results have since been obtained in comparisons of DR3 transport in T2 and in wild-type cells (Cresswell, P., and J. M. Riberdy, unpublished results) . We also previously showed that I-A k molecules expressed in "1"2 cells were transported to a proteolytic comparmaent, since incubation of T2-I-A ~ cells in leupeptin, a cysteine protease inhibitor, causes the accumulation of I chain fragments (leupeptin-induced proteins, or LIP) in association with I-A k molecules . LIP is produced by the partial inhibition of I chain proteolysis . We have similarly found that LIP is produced in association with HLA-DR3 molecules in leupeptin-treated T2.DR3 cells (Riberdy, J. M., unpublished results) . The ultimate I chain proteolysis product in T2.DR3 cells, however, is CLIP.
When isolated from T2.DR3 cells, CLIP is comprised of a nested set of invariant chain-derived peptides 16-24 amino acids in length which are also found associated with a number of class II alleles isolated from wild-type cell lines, suggesting that these peptides are naturally occurring breakdown products from proteolysis of the I chain (Chicz et al., 1992; Rudensky et ell., 1991; Hunt et al., 1992) . The abnormally high levels of CLIP association found with DR3 isolated from T2.DR3 prompted us to examine the kinetics of CLIP generation and dissociation in T2.DR3 and wild-type cells. Control Pala and mutant T2.DR3 cells were pulsed with [~sS]methionine for 30 rain and chased in the presence of 15-fold excess cold methionine for the indicated times. Cells were extracted and immunoprecipitated with the DR-specific monoclonal antibody L243. Immunoprecipitates were analyzed on SDS-PAGE gels using tricine as the trailing ion to better separate small peptides in the 1-5 kD range. The sequence information on CLIP would predict a 2-3 kD peptide species. Fig. 1 shows a distinct band in that range that coprecipitates with class II molecules from both Pala and T2.DR3. In Pala cells the putative CLIP species is transiently associated with class 1I and then dissociates during the later chase points. In contrast, the DR3 precipitates from T2.DR3 show a striking accumulation of the same low molecular weight species. Interestingly, the putative CLIP species is not detected until 20 h of chase in T2.DR3 cells, suggesting that the rate of proteolysis of I chain in the mutant cells is slower.
To confirm that the small peptide band seen in tricine gels is CLIP, Pala cells were labeled with [35S]methionine for 2 h and chased for 2, 4, or 24 h. DR3 molecules were affinity purified and associated labeled peptides were extracted, mixed with an unlabeled synthetic CLIP 24-mer, and subjected to reversed phase HPLC. The results are shown in Fig.  2 . At 2 h, three late-eluting 35S-labeled peaks are seen, eluting at 78 min, 83 rain, and 87 rain, respectively. Three identical peaks were seen when peptides were similarly isolated from DR3 molecules isolated from [35S]methioninelabeled T2.DR3 cells chased for 18-24 h (data not shown). The 87-min peak eluted coincidentally with the synthetic CLIP 24 mer (not shown), and the two earlier peaks are probably truncated versions of CLIP, previously seen in T2.DR3 cells . It is clear from Fig. 2 that the levels of these peaks are considerably decreased at 24 h, consistent with the tricine gel data shown in Fig. 1 .
As a further confirmation that the 2-3-kD band seen associated with HLA-DR3 molecules by tricine electrophoresis was CLIP, the three late-eluting [35S]methionine-labeled peaks, derived from T2.DR3 cells, were collected and analyzed by Tris-tricine gel electrophoresis. The mobility of the purified radiolabeled peptides on a tricine gel was identical to CLIP coprecipitated with I-ILA-DR3 from T2.DR3 by L243 (Fig. 3) . The tricine gel system presumably is incapable of resolving the minor Mr differences between the individual peptides. Finally, in an attempt to definitively show that the Pala-derived peaks were CLIP, the final peak (87 min elution) was subjected to Edman sequencing and the individual cycles collected and counted for 35S-content. The CLIP 24-mer has methionine residues at the 1 lth and 13th Figure 1 . Pulse-chase analysis of CLIP association. Pala and T2.DR3 cells were labeled with [~SS]methionine for 15 min and chased in the presence of a 15-fold excess of cold methionine for the indicated times. Immunoprecipitates of cell extracts were performed with a negative control antibody GAP.A3 or an anti-HLA-DR antibody L243 and subjected to Tristricine gel electrophoresis as described in Materials and Methods. The arrowhead indicates a low molecular weight peptide species that coprecipitates with HLA-DR3 and was later identified as CLIP (see below).
positions . 3sS was clearly obtained at the llth cycle, consistent with the pcptide lacing CLIP (data not shown). 35S was also present in the 13th cycle, although a clear '~rough" with zero counts was not obtained on the 12th cycle. This may be a consequence of some contamination with a pcptide with an additional residue on the NH2-terminus, or incomplete cleavage on the 11th cycle. Nevertheless, overall these data validate the pulse-chase experiment seen in Fig. 1 , suggesting that CLIP is generated , and 24 h, respectively. Cell lysates were subjected to affinity chromatography with an L243 anti-HLA-DR affinity column. The peak radioactive fractions were pooled. Acetic acid was added to a final concentration of 10% and peptides smaller than 10 kD were separated by filtration through a Centricon 10 filter unit. Synthetic CLIP 81-104 (30 ~g) was added to the radioactive pcptides and the preparations were separated by reversed phase HPLC. 30-s fractions were collected and assayed for psS]methionine cpm in a liquid scintillation counter. Absorbancc of the synthetic CLIP peptide was monitored at 210 nm and eluted with a retention time equivalent to the radioactivity collected in the last radioactive peak. The profile from the 2-h chase is represented by the dotted line, that from the 4-h chase by the solid line, and that from the 24-h chase by the thick solid line.
during intraceUular transport and is transiently associated with class II complexes in wild-type DR3-positive cells, whereas ct/~CLIP complexes accumulate later during biosynthesis in T2.DR3 cells.
IntraceUular Distribution of Class H and I Chain
The above biochemical analyses clearly demonstrated an alteration in the proteolysis and/or dissociation of I chain during biosynthesis in the mutant cell line T2.DR3. To determine if this affected the intraceUular distribution of class II molecules and associated I chain, the cells were examined Figure 3 . Purification of radiolabeled CLIP and Tris-tricine gel electrophorcsis. DR3 was purified from [35S]methionine labeled T2.DR3, denatured by addition of acetic acid and peptides separated by filtration through a Centricon 10 filter unit and reversed phase HPLC. The fractions corresponding to the three individual radioactive peaks in Fig. 4 were collected, lyophilizexi, and subjected to Tris-tricine gel electrophorcsis.
Figures 4-7. Electron micrographs of T1.DR3 (Fig. 4) , 12 (Fig. 5) , and 12.DR3 (Figs. 6 and 7). Cells were fixed in Karnovsky and embedded in Epon. Ultrathin sections were stained in uranyl Mg-acetate and Reynolds lead citrate. The 12.DR3 show huge vacuoles with internal membrane sheets and vesicles (asterisks) and surrounded by numerous larger vesicles, which were absent from TI.DR3 and T2. G, Golgi complex; M, mitochondrion; N, nucleus; Bars, 2/zm. by electron microscopy. For a wild-type control cell in these experiments T1.DR3, a DR3/~-transfectant of T1, the immediate parent of T2, was used. This cell expresses both DR3 and DR7, but like T2 cells, is a TxB hybrid and therefore a superior control to the Pala B-cell line for morphological studies. Figs. 4 and 5 show that TI.DR3 and "1"2 cells, respectively, have the same general morphology as that previously described in human B-cell lines (Peters et al., 199 lb) . Comparison of the control cell lines with mutant T2.DR3 ceils at low magnification reveals large, often irregularly shaped vacuoles with a diameter of up to 7 #m only in the mutant cells (see Figs. 4-7) . Numerous internal vesicles and membrane sheets are seen within these distended vacuoles (Fig.   7 ). Interestingly these structures are only found in I2 cells that have been transfected with DR3 genes and not in untransfected I2 cells (see Fig. 5 ). While we have not examined other class H transfectants of T2 by electron microscopy, we have found swollen vesicles which contain I-A k in T2.I-A k cells by immunofluorescence (Robbins, N., unpublished data). Thus, the presence of such vesicles is not a peculiarity of DR3 molecules themselves or the particular transfectant used.
In normal B-cell lines, most of the intracellular class II is present in MIICs which have typical lysosomai characteristics, i.e., contain lysosomal enzymes, lysosomal membrane proteins, lack marmose-6-phosphate receptors (MPR), are (Figs. 8-10 ) and of I2 (Fig. 11 ). Cells were fixed in 2 % paraformaldehyde, 0.5% glutaraldehyde in 0.1 M sodium phosphate, pH 7.4 for 2 h and stored in 1% paraformaldehyde, 0.1 M sodium phosphate, pH 7.4. Cells were embedded in 10% gelatin, solidified on ice and blocks were immersed in 2.3 M sucrose in phosphate buffer for 2 h at 4°C. Ultrathin cryosections of TI.DR3 or T2 cells were labeled with gold particles (either 10 ran or 15 nm) directly conjugated to antibodies against ~-hexosaminidase, class II molecules, CD63, and I chain, respectively. T1.DR3 cells were incubated with 30 mM DAMP at 37°C for 30 rain and washed with cold serum-free medium at 0°C for 4 min before immunogold labeling with anti-DNP antibodies which will recognize internalized DAMP in acidic compartments, as described above. Bars, 0.1 ~¢m. acidic and have a late position in the endocytic pathway (Peters et al., 1991b) . To investigate the nature of MIICs in T2.DR3 cells, immunogold labeling with antibodies against class II or-and/~-chains, I chain and a number of lysosomal/ MIIC markers was performed on ultrathin eryosections of T2.DR3 cells, as well as the control cell lines T1.DR3 and I2. TI.DR3 cells contain typical MIICs with abundant internal vesicles and membrane sheets (Figs. 8-10 ). The MIICs in T1.DR3 cells contain the lysosomal enzymes fl-hexosaminidase (Fig. 8) and cathepsin-D (not shown), the lysosomal membrane protein CD63 (Fig. 9) , lack CI-MPR (not shown), are acidic as indicated by the accumulation of the weak base 3-(2,4-dinitroanilino)-3-amino-N-methyldipropylamine, DAMP (labeled with an anti-DNP antibody, Fig.  10 ), and contain abundant class II molecules (Figs. 8, 10 , and 17 inset). Interestingly, MIICs containing I chain were also evident in T2 cells, but lack the same distended morphology as the irregular vacuoles found in T2.DR3 cells (Fig. 11) . The MIICs of T1.DR3 and T2 show variable labeling for the I chain cytoplasmic domain. Some MIICs are strongly labeled for I chain while others show hardly if any labeling (Fig. 9) . Most of the I chain labeling is associated with the content or with membranes in it, whereas the limiting membranes of the MIICs in T1.DR3 (Fig. 9 ) and I 2 (Fig. 11) are almost devoid of I chain label. The clear observation of I chain in MIICs in these experiments is probably because an antibody to the cytoplasmic tail was used, which can detect I chain after proteolysis of the lumenal region. Antibodies against the lumenal part of I chain only moderately label MIICs.
In any aspect studied except morphology, the huge vacuoles in T2.DR3 were characteristic of MIICs. Similar to the MIICs in T1.DR3, MIICs in "I2.DR3 were positive for/3-hexosaminidase (Fig. 12), CD 63 (Fig. 13) , lack CI-MPR (not shown), and are acidic (Fig. 14) , illustrating their lysosomal nature. Additionally, the MIICs in T2.DR3 contained abundant class 1I molecules and I chain (Figs. 12-15, 17) . I chain labeling in T2.DR3 was different from that in T1.DR3 in two aspects. First, MIICs in T2.DR3 contain a much larger fraction of the intracellular I chain. Secondly, most of the I chain in T2.DR3 was associated with the limiting membrane of the MIICs rather than with the content as in TI.DR3 (Fig. 9) and "I"2 (Fig. 11) . I chain labeling using antibodies to either cytoplasmic or lumenal domains was absent from the cell surface. The MIICs in TI.DR3 and I2 were often connected to and surrounded by tubules that label for I chain (Fig. 11) . The large vacuoles in 12.DR3 lack the tubules but are instead accompanied by numerous larger vesicles (Fig. 6) .
In favorably contrasted sections the lumenal face of the MIIC membranes, in particular of the limiting membrane, showed an electron dense layer (Fig. 16 ) which was less apparent in T1.DR3 and T2. Furthermore, MIICs in T2.DR3 contained electron dense globules (Figs. 14 and 16 ), which are reminiscent of those in the secretory lysosomes of cytotoxic T-cells (Peters et al., 1990 (Peters et al., , 1991a .
The position of MHCs in the endocytic pathway was studied by pulse-chase incubation of both T2.DR3 and T1.DR3 cells with 5-nm BSA/gold particles for 10+0, 10+30, 10+60, and 10+120 rain. Only a few endocytosed particles could be detected in the MHCs in I2.DR3 after 10+30 rain (Fig. 17) , whereas in T1.DR3 the MIICs already contain many particles after this period of endocytosis (see inset of Fig. 17 ). This is somewhat earlier than found previously in the B-ceU line JY where BSA/gold reaches MIICs only after 60 min (Peters et al., 1991b) . Thus, the microscopy studies show that T2.DR3 cells contain extraordinarily large, acidic MIICs with normal marker characteristics in which class II molecules and I chain seem to accumulate, and which are positioned late in the endocytic pathway. Fig. 1 demonstrates that CLIP accumulates with class 1I molecules in 12.DR3. It was unclear if otBCLIP primarily accumulates in the endosomal compartment defined by electron microscopy or whether ot/~CLIP was also found at the cell surface. Pala and "I2.DR3 cells were labeled with [35S]methionine for 6 h and chased in the presence of 15-fold excess of cold methionine for 3 and 20 h, respectively. At the end of each chase period, the cell surface proteins were biotinylated with NHS-LC-biotin, a membrane impermeable reagent reactive with primary amino groups. Duplicate samples were extracted and immunoprecipitated with a negative control mAb (GAP.A3), an anti-I chain antiserum that exclusively recognizes intracellular I chain (R.p35N), or an anti-DR monoclonal antibody (L243). One set of samples was analyzed by Tris-tricine electrophoresis as a control for the total amount of protein precipitated by the individual antibodies. Both the R.p35N and L243 sampies showed significant amounts of protein precipitated with each antibody (data not shown). The remaining set of sampies were eluted from the protein A beads by alkaline elution (pH 11.5) and the supernatants were neutralized by addition of acetic acid before dilution with 10-fold excess lysis buffer. The cell surface proteins were then specifically precipitated with avidin-agarose beads and the samples were analyzed on Tris-tricine gels. Fig. 18 clearly shows that cell surface DR3 complexes isolated from T2.DR3 molecules are associated with CLIP, while DR3 molecules from the Pala sample do not contain CLIP. The lack of avidin-precipitable protein bands isolated from the anti-p35N precipitates shows that the technique is not recognizing intracellular proteins. Thus, CLIP is found at the cell surface in T2.DR3 cells, while wildtype Pala cells do not express ot/~CLIP at the cell surface in amounts detectable by this procedure.
CLIP Peptides at the Cell Surface
Discussion
The data described in this paper argue that the early stages of class II-invariant chain complex assembly and transport are similar in 12.DR3 and wild-type cells. After assembly the complexes are transported through the Golgi. In wildtype B-cell lines and in the parental hybrid T1.DR3, the class II-invariant chain complexes are then delayed in transit, probably in MIIC, the prelysosomal or lysosomal compartment previously defined by electron microscopy. In T2.DR3 cells the dominant pool of intracellular class II molecules is found in the large multivesicular compartments described in this paper. These vacuoles contain the same complement of markers as the previously defined MIIC, and are like wildtype MIIC except for their morphology. We consider the most likely explanation for their origin to be that they represent MIIC which are swollen and distended. Presumably this gross morphological change is a consequence of the mutation in the T2.DR3 cell line responsible for defective antigen processing.
The normal proteolysis of invafiant chain is severely affected in "I2.DR3 cells. The pulse-chase studies shown in Fig. 1 demonstrate this clearly. In the wild-type cells a number of lower molecular weight class H-associated bands appear during the chase which are characteristic of a protein undergoing progressive proteolytic degradation, and these bands are presumably fragments of the invariant chain. It has previously been shown that oL/3 dimers associated with LIP, a leupeptin-induced partial proteolytic fragment of the invariant chain retaining the cytoplasmic domain, are reactive with L243, the mAb used for these experiments . One of the bands has an Mr similar to that of a previously described 11-kD I chain fragment (Nguyen et al., 1989) . Between 2--4 h the lowest Mr fragment transiently appears. We have characterized this as CLIP, a nested set of I chain-derived peptides from residues 81-104 (Figs. 2 and 3 ). Since CLIP acts as a competitive inhibitor of antigenic peptide binding , the removal of this peptide from class II molecules is presumably essential for antigen presentation to occur. Its ultimate disappearance from DR3 molecules in the wild-type cell Figure 18 . Identification of cell surface CLIE Pala and T2.DR3 cells were labeled with [35S]methionine for 6 h and chased in the presence of a 15-fold excess of cold methionine for 3 and 20 h, respectively At the end of each chase point, the ceil surface proteins were biotinylated with the amino-reactive biotin derivative, NHS-LCbiotin. Duplicate cell extracts were immunoprecipitated with a negative control antibody, GAP.A3, an antibody recognizing only intracellular p35 I chain, R.Ip35N, or an HLA-DR specific antibody L243. One set of immunoprecipitates was subjected to Tris-tricine gel electrophoresis (data not shown). The other set of immunoprecipitates were eluted off the protein A-Sepharose beads by alkaline elution, pH 11.5. Eluates were neutralized by addition of 7 ml 1 M acetic acid and diluted to 1 ml in 0.1% Cz2E9 column buffer. Cell surface proteins were specifically precipitated with avidinagarose beads and subjected to Tris-tricine gel electrophoresis.
probably reflects the loading of antigenic peptides and the acquisition of an SDS-stable phenotype for a large proportion of them. In the 12.DR3 cells, the fragmentation pattern of invariant chain is radically different, and CLIP is generated at a much slower rate. The slow generation of CLIP is consistent with the observed accumulation of I chain in T2.DR3 vesicles relative to TI.DR3 M1/C (Figs. 15 and 16 ). Despite the differences in the degradation pattern of I chain in "12.DR3 cells, CLIP is ultimately generated. However, CLIP does not efficiently dissociate during biosynthesis (Fig. 1) . The inability to efficiently eliminate CLIP may be associated with the inability to properly load antigenic peptide in the enlarged M1/C compartment.
Degradation of the invariant chain resulting in removal of the cytoplasmic domain is probably required for the delivery of mature c~/3 dimers to the cell surface Neefjes and Ploegh, 1992) . It has been argued that the invariant chain contains an endosomal retention signal in the cytoplasmic domain as well as a targeting signal (Bakke and Dobberstein, 1990) . Ploegh and co-workers have also shown that DR molecules associated with LIP are not transported from the endosomal system to the plasma membrane (Neefjes and Ploegh, 1992) . Thus, a reduced rate of invariant chain degradation would be expected to result in prolonged retention of class II molecules in the endosomal system. We have attempted by various techniques to precisely determine the transit time from ER synthesis to the plasma membrane for DR3 molecules in 12.DR3 but have been unsuccessful. In wild-type Pala cells, using a cell surface biotinylation approach, we were able to detect some DR3 molecules on the cell surface within 30 min, with complete transport in 2--4 h (data not shown). This is somewhat faster than has been previously seen in other B-cell lines . In similar experiments we could not detect any cell surface expression in 12.DR3 within 8 h. Cell surface expression is clearly detectable at 24 h (Fig. 18 ), but we have not quantitated the percentage of the class 1/ molecules which successfully complete the journey from the ER. Overall, the data argue that class 1/expression on the cell surface is delayed in T2.DR3 relative to wild-type cells, that the delay probably results from a reduced rate of invariant chain proteolysis, and that the class II accumulates in the vacuoles defined by electron microscopy which have characteristics of M1/C but are morphologically dramatically different.
The precise reason for the generation of the large vesicles in T2.DR3 is unknown. It is conceivable that they enlarge simply because class II-invariant chain complexes accumulate in them, as has been proposed to occur in transfected cell lines expressing invariant chain (Romagnoli et al., 1993) . The presence of class 1/is clearly necessary since untransfected I2 cells which have I chain, but lack class 1/ genes, do not contain distended M1/C. This would argue that the enlarged MIIC are not merely a general defect, but are specifically associated with the accumulation of class II molecules within that compartment. The swollen MIIC cannot be due to a simple defect in acidification as imrnunogold labeling with DNP clearly shows that the compartment is acidic (Fig. 10) . Presumably, enlarged vesicles containing exclusively I chain do not occur in untransfected T2 cells because I chain, without class 1/molecules, predominantly remains in the ER (Marks et al., 1990; Lamb and Cresswell, 1992) . The small number of normal M1/Cs in 12 (Fig. 11) may result from the very small fraction of invariant chain (933 homotrimers) which successfully escapes the ER (Lamb and Cresswell, 1992) . The fact that M1/Cs form in 12 argues that their formation is independent of class 1/expression, and suggests that the invariant chain itself may be responsible for generating the structure.
At least two plausible explanations exist to explain the in vivo association of CLIP with class 1/molecules derived from wild-type cells. One is that CLIP is a free peptide generated during the proteolysis of I chain which has a significant binding affinity for a range of class 1/alleles. Class II binding peptides generated from the normal complement of exogenous proteins would then compete with CLIP for the binding cleft of the newly liberated or/3 heterodimer. Incomplete competition would result in some o~B-CLIP complexes being formed. Alternatively, CLIP could remain as a residual-associated fragment of I chain after its proteolysis. This could be a region of the I chain in contact with c~/3 dimers in otBI complexes, bound in the peptide-binding groove in the same manner as a conventional peptide. Induction of CLIP dissociation by unknown mechanisms would then be required to generate oeB dimers competent to bind peptide. If the dissociation was incomplete, ,B-CLIP corn-plexes would remain. The pulse-chase studies (Fig. I) indicate that CLIP is generated during the biosynthesis of class II molecules, is transiently associated with the class II complex, and dissociates at later time points. This result is probably more consistent with CLIP remaining as a residual class H-associated fragment after invariant chain proteolysis. Whatever mechanism is responsible for inducing CLIP dissociation and/or binding cndocytically generated peptidcs is presumably defective in T2.DR3 and may bc associated with the distention of the MIIC in that cell line.
To draw any conclusions about the kinetics of CLIP generation and association in wild-type cells, it was crucial to show that the smallest molecular weight band seen in Fig.  1 was CLIP. The purification of metabolically labeled class H-associated peptidcs from T2.DR3 and Pala cells that had been pulsed and chased showed that at least one of the peptide peaks from the reversed phase HPLC profiles comigrated precisely with non-labeled synthetic CLIP, and this peak had a methionine residue in the expected 11th position. The synthetic 24-mer used was the longest of the CLIP peptides that were originally sequenced and the last to be cluted from the C18 column. Thus, cornigration with the last radioactive peak is expected. Also, the original steady state profiles of endogenous peptides associated with DR3 from T'2.DR3 showed four distinct peptide peaks, all containing a CLIP derivative. Thus, the characteristic profile of multiple radiolabeled pcptide peaks associated with class II molecules purified from Pala and T2.DR3 is consistent with all peaks containing CLIP. The fact that the radioactive samples generate chromatograms containing three peaks instead of the four peaks previously observed is most likely duc to a loss in resolution because the radioactive peaks arc actually collected fractions, not continuous absorbance readings. Together, these data confirm that the labeled peptidcs seen on Tris-tricine gels that arc associated with the class II molecules in T2.DR3 and Pala arc CLIP and thereby validate the pulse-chase experiment examining the kinetics of CLIP generation.
CLIP is clearly associated with surface DR3 in T2.DR3 (Fig. 18) . The apparent lack of CLIP associated with the class II complexes at the cell surface in Pala suggests that in wild-type cells CLIP may dissociate before arrival at the ccU surface. The obvious extension of these observations is that in wild-type cells, class II molecules bind endocytic peptidcs and/or simultaneously dissociate from CLIP before their arrival at the cell surface. We have previously shown that an acidic pH facilitates the binding of an antigenic peptidc to DIL3 molecules purified from T2.DR3, consistent with this occurring in an endosomal compartment. However, CLIP dissociation fails to occur in T2.DR3 in vivo, suggesting that acidification is not the only requirement. Also, the level of sensitivity of the biotinylation assay used to determine the lack of CLIP at the cell surface is uncertain and a small percentage of c~B dimers at the cell surface in wild-type cells could contain CLIP. The results shown in Fig. 18 do show, however, that CLIP dissociation is not an absolute requirement for transport of HLA-DR3 molecules to the cell surface.
Recent reports by Romagnoli et al. (1993) suggest that there may well be more than one post-Golgi compartment that class II molecules traverse during biosynthesis in which antigen processing is facilitated. These data suggest that certain events such as complete and efficient invariant chain proteolysis or antigenic peptide loading may need to occur in order to have efficient transport to the next biosynthetic compartment. Since T2.DR3 cells do not process and present antigenic proteins well, nor do they bind a normal repertoire of peptides intraceUularly, it is reasonable to propose that the defect in these cells is in accessibility to peptides. MIICs have been shown to be part of both the biosynthetic pathway of class II molecules and the endocytic pathway, and are probably positioned at the intersection of these routes (Neefjes et ai., 1992). They contain hydrolytic enzymes and are acidic and are therefore candidates for a compartment in which antigen is processed and peptide is loaded on to the class II molecules. Indeed, recent studies on macrophages have shown that antigenic peptides are efficiently generated and may be loaded on to class II molecules in a late endocytic compartment with characteristics of MIIC (Harding et al., 1991; Harding and Geuze, 1993) . How MIIes are formed from post-Golgi intermediates has not yet been elucidated. It is not known in what type of vesicles o~BI complexes exit the Golgi en route to the next station in transport, presumably the MIIC. The absence of small tubules and vesicles normally present around MIICs and the accumulation of larger vesicles (see Fig. 6 ) in T2.DR3 may reflect a defect in the formation of MIIes resulting in an improper sorting of class II complexes to the compartment where endocytically generated peptides reside. Conversely, there may be defects in transporting peptides to the compartment where the liberated class II (x/~ dimers reside. Any of these scenarios could result in the accumulation of class II molecules in MIIC and ultimately a defect in class II antigen presentation. Further investigation of the processes involved in dissociating CLIP and binding peptide in the MIIC are needed to determine the mechanisms which generate the distended MIIC in these cells.
